Have you or a loved one taken the prescription drug Valsartan and been diagnosed with
You may be entitled to financial compensation!
On July 13, 2018, the United States Food and Drug Administration (FDA) alerted healthcare professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan. The FDA’s recall is due to the unexpected presence of an impurity found in the recalled products called N-nitrosodimethylamine (NDMA), which the FDA has classified as a probable human carcinogen.
- Liver damage, including liver fibrosis and scarring of the liver.
- Tumors of the liver.
- Liver cancer.
Call us today at 1-800-229-7989 for a FREE case evaluation!